Romvimza Capsule
NDC Package 73207-302-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Romvimza (vimseltinib) capsules is rOMVIMZA is indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity. This formulation utilizes a capsule delivery system. Marketed by Deciphera Pharmaceuticals, Llc, this product is identified by NDC 73207-302 and is authorized under FDA application NDA219304.

Identification & Billing

NDC Package Code
73207-302-41
Package Description
1 CARTON in 1 CARTON / 1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK
Product Code
73207-302
11-Digit Billing Format
73207030241
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Romvimza
Non-Proprietary Name
Vimseltinib
Substance Name
Vimseltinib
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
VIMSELTINIB 14 mg/1
Pharmacologic Class
Usage Information
ROMVIMZA is indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity.

Regulatory & Marketing

Labeler Name
Deciphera Pharmaceuticals, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA219304
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-14-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73207-302). Click a package code to view its specific billing and regulatory data.

73207-302-40
1 CARTON in 1 CARTON / 1 BLISTER PACK in 1 CARTON / 8 CAPSULE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73207-302-41 identifies a specific commercial package of 1 carton in 1 carton / 1 blister pack in 1 carton / 4 capsule in 1 blister pack of Romvimza, a human prescription drug labeled by Deciphera Pharmaceuticals, Llc. This capsule is formulated for oral use and contains vimseltinib as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deciphera Pharmaceuticals, Llc on February 14, 2025. The current certification is valid through December 31, 2026.

How is this Deciphera Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73207030241. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73207-302-41
11-Digit CMS (5-4-2)
73207-0302-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.